NCT00791557View on ClinicalTrials.gov

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

February 28, 2010

Conditions
Pyoderma GangrenosumCrohn's DiseaseUlcerative ColitisInflammatory Bowel Disease
Interventions
DRUG

Infliximab

IV drug given at weeks 1,2,14,22

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Cleveland

Sponsors

Collaborators (1)

Centocor, Inc.
All Listed Sponsors
collaborator

Centocor, Inc.

INDUSTRY

lead

University Hospitals Cleveland Medical Center

OTHER